Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Merck & Co (NY: MRK )

129.88 +2.88 (+2.27%)
Streaming Delayed Price Updated: 12:11 PM EDT, Apr 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Merck & Co

< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
65 66 Next >
Merck Gets FDA Fast Track Status For Chronic Kidney Disease Candidate
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Merck's (NYSE: MRK) lead asset MK-2060 for the reduction in risk of major thrombotic cardiovascular events in patients... 
Via Benzinga
Gilead's Lenacapavir Scores European Approval For Pretreated HIV Patients After Manufacturing Delays
Via Benzinga
Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday, August 22
Reuters Vodafone To Sell Hungarian Business For $1.8B: Report 
Via Benzinga
FDA Says Study Needed To Assess Another Round Of Pfizer's COVID-19 Pill As Infection Rebounds
The FDA has asked Pfizer Inc (NYSE: PFE) to test an additional course of its antiviral Paxlovid among people who experience a rebound in COVID-19 after treatment. 
Via Benzinga
Merck Bets $250M On Next-Gen Approach To mRNA For Infectious Diseases, Cancer
Via Benzinga
Merck Re-enters Alzheimer's R&D With Research Pact With Cerevance
Via Benzinga
Looking For Ebola Virus Meds? WHO Recommends These Two Antibody Treatments
Via Benzinga
Covid Stocks Pfizer, Moderna, Novavax Face Their Next Challenge, And It's Worth Billions
How they handle an upcoming shift in payments will be telling for their tailwind. 
Via Investor's Business Daily
Could This Company's HyBryte™ Provide A Safer, More Convenient Alternative To Cutaneous T-Cell Lymphoma Treatment?
Patients always have hope if their cancers are detected early. Thanks to advanced research and therapies, the earlier the cancer is diagnosed and treated, the better the chance of it being cured. 
Via Benzinga
Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
3 Top Stocks to Invest In Right Now
Every investor is looking for the top stocks to invest in. These three options will provide you with both offense and defense. 
Via InvestorPlace
Seagen For Sale? This Acquisition Target Is 'Too Intriguing To Ignore,' RBC Says
The recent pressure on Seagen Inc.’s (NASDAQ: SGEN) stock may offer a nearer-term opportunity, but the biotech's position as an attractive strategic target is “too intriguing to ignore.” 
Via Benzinga
AstraZeneca-Merck's Prostate Cancer Drug Under FDA Priority Review For Expanded Use
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Seagen Suffers Loss In Arbitration Dispute Over ADC Technology
Via Benzinga
Does Merck Finally Have The Fodder It Needs To Buy Seagen?
The final piece ahead of a potential Seagen buyout took place Friday and shares rose. 
Via Investor's Business Daily
Senate Finance Committee Expands Amgen's Tax Probe: Report
Senator Ron Wyden sent a letter to Amgen Inc (NASDAQ: AMGN) asking what methods the company has used to pay an average effective tax rate of around 12% over the past four years.  
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
  This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
Recap Of Thursday's Biotech Catalysts - End Of the Day Summary
Via Benzinga
Merck & Co Whale Trades For August 11
  A whale with a lot of money to spend has taken a noticeably bearish stance on Merck & Co. Looking at options history for Merck & Co (NYSE:MRK) we detected 10 strange trades. 
Via Benzinga
ALX Oncology Shares Climb As Mid-Stage Triple Combination Colorectal Cancer Study Kicks-off
ALX Oncology Holdings (NASDAQ: ALXO) has initiated a Phase 2 investigator-sponsored study of evorpacept in combination with Eli Lilly’s (NYSE: LLY) ERBITUX (cetuximab) and Merck’s (NASDAQ: 
Via Benzinga
Stocks Log Solid Wins As Inflation Concerns Ease
Stocks managed to sustain their impressive rallies on Wednesday, which came on the heels of a consumer price index (CPI) that signaled cooling inflation. 
Via Talk Markets
Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Benzinga Before The Bell: Elon Musk Sells $6.8B Tesla Shares, Nio Begins ES7 Test Drives, Coinbase Accused Of Misleading Investors And Other Top Financial Stories Wednesday, August 10
Wall Street Journal 
Via Benzinga
To Avoid Supply Crunch, FDA Temporarily Allows Higher Impurity Levels In Merck's Diabetes Drug: Report
The FDA recently became aware of a nitrosamine impurity, Nitroso-STG-19 or NTTP, in certain samples of Merck & Co Inc's (NYSE: MRK) type 2 diabetes drug Januvia/Janumet (sitagliptin). 
Via Benzinga
The 3 Best Vanguard Funds to Buy in August
VCR, VHT and VYM are among the best Vanguard funds to buy now. Here is why they will make great investments in the coming months. 
Via InvestorPlace
Amgen's Lumakras/Keytruda/Tecentriq Combo Data Flags Safety Concern
Via Benzinga
Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
An estimated 200 million Americans — more than 60% of the population — suffer from at least one neurological disorder. That includes dementia, strokes, migraines and other diseases or infections that... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
CNBC's Final Trades: Iron Mountain, Porsche And This Health Care Company
On CNBC’s “Halftime Report Final Trades,” Jenny Harrington of Gilman Hill Asset Management said Iron Mountain Inc (NYSE: IRM) represents “the best of both worlds.” &ldqu 
Via Benzinga
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
65 66 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.